Organon & Co. (OGN)
13.35
+0.03
(+0.23%)
USD |
NYSE |
May 08, 16:00
13.30
-0.05
(-0.37%)
After-Hours: 20:00
Organon Shareholders Equity (Quarterly) : 903.00M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Merck & Co., Inc. | 45.88B |
| Eli Lilly & Co. | 31.20B |
| Ligand Pharmaceuticals, Inc. | 997.32M |
| Veradermics, Inc. | 145.31M |
| Johnson & Johnson | 81.19B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 13.00B |
| Total Liabilities (Quarterly) | 12.09B |
| Debt to Equity Ratio | 9.490 |
| Current Ratio | 1.973 |
| Net Debt Paydown Yield | 5.94% |